Literature DB >> 12105124

Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells.

M T Oliveira1, A C Rego, M T Morgadinho, T R A Macedo, C R Oliveira.   

Abstract

Cell death and reactive oxygen species production have been suggested to be involved in neurodegeneration induced by the drugs of abuse. In this study we analyze the toxicity of the following drugs of abuse: heroin, morphine, d-amphetamine, and cocaine in undifferentiated PC12 cells, used as dopaminergic neuronal models. Our data show that opioid drugs (heroin and morphine) are more toxic than stimulant drugs (d-amphetamine and cocaine). Toxic effects induced by heroin are associated with a decrease in intracellular dopamine, an increase in DOPAC levels, and the formation of ROS, whereas toxic effects induced by amphetamine are associated with a decrease in intracellular dopamine and in ATP/ADP levels. In contrast with cocaine, both amphetamine and heroin induced features of apoptosis. The data suggest that the death of cultured PC12 cells induced by the drugs of abuse is correlated with a decrease in intracellular dopamine levels, which can be associated with an increased dopamine turnover and oxidative cell injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105124     DOI: 10.1111/j.1749-6632.2002.tb04190.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study.

Authors:  Susan M Lantz; Hector Rosas-Hernandez; Elvis Cuevas; Bonnie Robinson; Kenner C Rice; William E Fantegrossi; Syed Z Imam; Merle G Paule; Syed F Ali
Journal:  Neurosci Lett       Date:  2017-07-03       Impact factor: 3.046

2.  Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.

Authors:  Sirirat Klongpanichapak; Piyarat Govitrapong; Sushil K Sharma; Manuchair Ebadi
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats.

Authors:  T Iida; H Yi; S Liu; D Ikegami; W Zheng; Q Liu; K Takahashi; Y Kashiwagi; W F Goins; J C Glorioso; S Hao
Journal:  Gene Ther       Date:  2017-04-03       Impact factor: 5.250

5.  Context- and time-dependent neurobiological and behavioral sensitization induced by a single morphine exposure in mice.

Authors:  Wang-Jun Qin; Yan-Ting Wang; Peng-Mei Li; Xiao-Xing Wang; Jun-Xu Li; Hamid R Noori; Rick E Bernardi; Jian-Hui Liang; Xiang-Lin Zhang
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

6.  Regulation of rat MOR-1 gene expression after chronic intracerebroventricular administration of morphine.

Authors:  Zhi-Ping Zhu; Ramesh B Badisa; Donald E Palm; Carl B Goodman
Journal:  Mol Med Rep       Date:  2011-11-15       Impact factor: 2.952

7.  Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment.

Authors:  Susanne Ammon-Treiber; Gisela Grecksch; Ralf Stumm; Uta Riechert; Helga Tischmeyer; Anke Reichenauer; Volker Höllt
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

8.  Morphine-induced apoptosis in the ventral tegmental area and hippocampus after the development but not extinction of reward-related behaviors in rats.

Authors:  Yasaman Razavi; Shabnam Zeighamy Alamdary; Seyedeh-Najmeh Katebi; Fariba Khodagholi; Abbas Haghparast
Journal:  Cell Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.046

Review 9.  Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.

Authors:  Jean Lud Cadet; Irina N Krasnova; Subramaniam Jayanthi; Johnalyn Lyles
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Xian-Feng Shi; Douglas G Kondo; Kelly J Lundberg; Erin C McGlade; Tracy L Hellem; Rebekah S Huber; Kristen K Fiedler; Renee E Harrell; Bethany R Nickerson; Seong-Eun Kim; Eun-Kee Jeong; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2012-10-18       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.